Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karl H. Nollstadt is active.

Publication


Featured researches published by Karl H. Nollstadt.


Bioorganic & Medicinal Chemistry Letters | 1995

ANTIFUNGAL LIPOPEPTIDES : STRUCTURE-ACTIVITY RELATIONSHIPS OF 3-HYDROXYGLUTAMINE-MODIFIED PNEUMOCANDIN B0 DERIVATIVES

Robert A. Zambias; Catherine James; Milton L. Hammond; George K. Abruzzo; Kenneth F. Bartizal; Karl H. Nollstadt; Cameron M. Douglas; Jean A. Marrinan; James M. Balkovec

Abstract Selective methanolysis or dehydration followed by reduction of the 3-hydroxyglutamine residue of pneumocandin B0 (1) or its dideoxy analog 5 (L-692,289) gave the methyl 3-hydroxyglutamate and 3-hydroxyornithine analogs 6 and 9, respectively. Further derivatization of these analogs allowed a study of the SAR at this position. In general, carboxylic acid-containing derivatives were poorer antifungal agents than neutral derivatives while amine-bearing analogs displayed the greatest potency.


Bioorganic & Medicinal Chemistry Letters | 1997

Lipopeptide antifungal agents: Amine conjugates of the semi-synthetic pneumocandins L-731,373 and L-733,560

Robert A. Zambias; Catherine James; George K. Abruzzo; Kenneth F. Bartizal; Richard Hajdu; Randy Thompson; Karl H. Nollstadt; Jean A. Marrinan; James M. Balkovec

Abstract Amine conjugates of the semi-synthetic 1,3-β-(D)-glucan synthesis inhibitors L-731,373 (3) and L-733,560 (4) were prepared and evaluated for in vitro and in vivo antifungal activity. Tricationic analogs were more potent than the dicationic which were more potent than the monocationic. The L-ornithine conjugate of 4 possessed excellent pharmacokinetic parameters but lacked sufficient antifungal spectrum for development.


Journal of Chromatography B: Biomedical Sciences and Applications | 1989

Potential of the sulfobetaine detergent zwittergent 3-12 as a desorbing agent in biospecific and bioselective affinity chromatography

Karl H. Nollstadt; Yashwant D. Karkhanis; Mark J. Gnozzio; Mark S. Crane; Anne Gurnett; Dennis M. Schmatz; Mervyn J. Turner

The isolation in our laboratories of several antigens of interest from sporulated oocysts of Eimeria species by bioselective adsorption on matrices containing immobilized antigen-specific immunoglobulins IgG was initially unsuccessful. The preparations serving as source materials for these antigens contained low levels of the zwitterionic sulfobetaine detergent, Zwittergent 3-12. Since usually immunoaffinity processes are carried out in the presence of various detergents, we were surprised, subsequently, to find this detergent to be the cause of the problem in that it prevented antigen-antibody binding. These findings led us to study the potential role of Zwittergent 3-12 as an eluting agent from matrices holding bioselectively adsorbed materials. The results of seven case studies are presented in this paper and include experiments with beta-D-galactosidase adsorbed biospecifically and bioselectively on matrices via either specific antibody or inhibitor analogue. In all cases, Zwittergent 3-12 proved to be an effective desorbing agent.


Proceedings of the National Academy of Sciences of the United States of America | 1990

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Dennis M. Schmatz; M A Romancheck; L A Pittarelli; Robert E. Schwartz; Robert A. Fromtling; Karl H. Nollstadt; Frank Vanmiddlesworth; Kenneth E. Wilson; M J Turner


The Journal of Antibiotics | 1991

L-687,781, a new member of the papulacandin family of beta-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity.

Frank Vanmiddlesworth; Mary Nallin Omstead; Dennis M. Schmatz; Ken Bartizal; Robert A. Fromtling; Gerald F. Bills; Karl H. Nollstadt; Susan S. Honeycutt; Marcia Zweerink; George M. Garrity; Kenneth E. Wilson


Archive | 1981

Group B streptococcal capsular polysaccharides

Dennis J. Carlo; Karl H. Nollstadt; Thomas H. Stoudt; Robert Z. Maigetter


Archive | 1978

Pneumococcal vaccine and a process for its preparation.

Dennis J. Carlo; Karl H. Nollstadt; Thomas H. Stoudt; Robert Bruce Walton; Johanna Y. Zeltner


Archive | 1980

Process of producing modified glucans as anti-caries agent

Thomas H. Stoudt; Karl H. Nollstadt


Archive | 1989

Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines

Paul A. Liberator; Karl H. Nollstadt; Mervyn J. Turner; John Crane Mark; Yashwant D. Karkhanis; Prasanta R. Chakraborty; Profous-Juchelka


Archive | 1973

Oral hygiene enzymes and method for preparation

Thomas H. Stoudt; Karl H. Nollstadt

Researchain Logo
Decentralizing Knowledge